IngredientsHoney is a natural sweet substance produced primarily by the western honeybee, Apis mellifera, from the nectar of flowering plants or from secretions of plant-sucking insects (honeydew). Honey is a viscous, supersaturated sugar solution derived from nectar gathered and modified by the honeybee, Apis mellifera. The bees enzymatically transform the collected nectar before depositing it in the honeycomb, where water evaporation concentrates it into the familiar thick liquid. The bees use a special enzyme in their digestive systems to help process the nectar, then place it into honeycombs and use their wings to create a breeze that dries and cures it, eventually resulting in honey.
From a chemical point of view, honey could be defined as a natural food mainly composed of sugars and water together with minor constituents such as minerals, vitamins, amino acids, organic acids, flavonoids and other phenolic compounds and aromatic substances. According to the literature, honey contains over 300 substances belonging to various groups of chemical compounds, some with antioxidant activity, including vitamins and phenolic compounds, mainly flavonoids and phenolic acids.
In terms of macrocomposition, honey is a highly concentrated water solution of two principal sugars, fructose and glucose, together with small amounts of at least 22 other more complex sugars, several natural enzymes, 11 minerals, 12 amino acids, and 9 vitamins. The high concentration of fructose (38%) and glucose (31%) influences many of the characteristic properties of honey: high viscosity, "stickiness," high density, hygroscopicity, granulation tendencies, antibacterial activity, and immunity from some types of spoilage. The water content of natural honey may vary between 13% and 25%; under the United States Standards for Grades of Extracted Honey, honey must not contain more than 18.6% water to qualify for U.S. Grade A.
Depending on its origin, honey can be classified into different categories, among which monofloral honey seems to be the most promising and interesting as a natural remedy. Manuka honey, a monofloral honey derived from the manuka tree (Leptospermum scoparium), has greatly attracted the attention of researchers for its biological properties, especially its antimicrobial and antioxidant capacities. Polyfloral (or wildflower) honeys derive from the nectar of many plant species and exhibit a broader but less predictable phytochemical profile. Honey's phenolic composition is mostly determined by its floral origin; in fact, this characteristic can be utilized to classify and authenticate honey, particularly in the case of unifloral types.
Human use of honey is traced to some 8,000 years ago as depicted by Stone Age paintings. The use of honey as an internal and external health agent is much older than the history of medicine itself. The earliest recorded medical prescription including honey is from Sumer.
In ancient Egypt, the Edwin Smith Papyrus (circa 1600 BCE) and Ebers Papyrus (circa 1550 BCE) contain numerous references to honey in medical treatments, particularly for wound care. Honey was mentioned 500 times in 900 documented remedies in ancient Egyptian texts. The first evidence of organized beekeeping has been traced back to ancient Egypt, circa 3,500 BC.
Honey was used as a remedy against a variety of illnesses in ancient Egypt, Greece, and Rome. There are frequent references to honey in sacred texts. Hippocrates, the father of modern medicine, prescribed a mixture of honey, water, and various medicinal substances for pain, fever, and wound treatment, noting "Honey gives good food and good health." A drink containing honey and unfermented grape juice, known as oenomel, was used by ancient Greeks as a remedy for gout and nervous disorders. Hippocrates also used honey for a variety of ailments including baldness, cough, and sore throat, and mixed it with vinegar, creating oxymel, to relieve pain. In ancient Greece, Hippocrates used honey as a base for most of his formulations, a practice continued in the works of the medical greats such as Galen and Dioscorides.
We have more than 4,000 years of recorded use of honey as medicine from the ancient world to the present. It has even been successfully used as battlefield medicine from the time of The Iliad to as recently as World War I.
Traditional Chinese medicine texts dating back to the Han Dynasty (206 BCE to 220 CE) document honey's use for digestive ailments, cough relief, and detoxification. The Chinese believed that honey as a medicine has a "balanced character" (neither yin nor yang) and acts as an Earth element, working within the lungs, spleen, and large intestine. Honey was mentioned as medicine by Shen Nang, circa 2,000 BC, when it was cited as being used in cases of bacterial infections, rheumatoid arthritis, gastrointestinal distress, and to help heal open wounds.
Ayurvedic medicine, developed in the Indian subcontinent, incorporated honey into treatments for eye diseases, respiratory conditions, and skin disorders. In Ayurvedic medicine that arose in ancient India, practitioners recognized 8 different types of honey, each with unique healing properties.
Honey was not commonly used by medical practitioners after the fall of the Roman Empire. In medieval times honey was not a popular subject of medical texts and very little was written on its use in that period. However, honey has a long tradition, not only in Western medicine but also in traditional Chinese medicine and Ayurveda.
The dominant components of honey are monosaccharides. Honey's sugar fraction comprises approximately fructose (38.5%), glucose (31%), maltose (7%), trisaccharides (4%), and sucrose (1.5%). The remaining mass is primarily water, with the balance constituted by a diverse suite of minor bioactive compounds. Honey's fructose concentration is known to correlate negatively with the glycaemic index. Small quantities of fructose have been demonstrated to cause a reduction in blood glucose levels by improving hepatic glucose uptake by activating the glucokinase enzyme.
Key enzymes introduced by the bee during honey production include glucose oxidase, invertase (sucrase), and diastase (amylase). The glucose is oxidised by glucose oxidase upon the addition of oxygen, producing D-glucono-δ-lactone and hydrogen peroxide. The hydrogen peroxide has antimicrobial activity. Diastase activity is used as a standard quality marker for honey; heating degrades this enzyme and its measurement can indicate overprocessing.
Hydrogen peroxide (Hâ‚‚Oâ‚‚) is one of the most essential factors responsible for the antibacterial activity of honey. In honey, hydrogen peroxide is produced by an enzymatic reaction during the transformation of nectar into honey by gluco-oxidase under aerobic conditions.
Other constituents of interest found in manuka honey are different 1,2-dicarbonyl compounds, such as glyoxal (GO), 3-deoxyglucosulose (3-DG) and methylglyoxal (MGO). Methylglyoxal is one of the dicarbonyl components resulting from the Maillard reaction which takes place in all products very rich in sugars, such as nectar. This molecule has a powerful bactericidal power and its content varies according to the geographical and floral origin of the honey and it has a strong correlation with its antibacterial effect. MGO is particularly concentrated in manuka honey derived from Leptospermum scoparium in New Zealand, where precursor dihydroxyacetone (DHA) is uniquely abundant in the plant's nectar.
Bee defensin-1 is a small peptide with molecular weights ranging from 3.5 to 6 kDa made by the hypopharyngeal and mandibular glands of bees, and possesses a strong antibacterial activity but only against Gram-positive bacteria. The antibacterial peptide defensin-1 (Def-1) obtained from bees is the main ingredient responsible for the antibacterial activity of honey, except for Manuka honey.
The primary medicinal properties of honey are ascribed to its polyphenol content, since these compounds are the most prevalent phytochemicals and have drawn significant interest from scientific communities as potential preventive agents against degenerative and chronic inflammatory diseases. Flavonoids and polyphenols, which act as antioxidants, are two main bioactive molecules present in honey. Beyond MGO, manuka honey is a rich source of phenolic compounds, including protocatechuic acid, syringic acid, and genistic acid, as well as flavonoids such as quercetin, luteolin, kaempferol, and apigenin. The specific phenolic profile of any given honey is largely dictated by the plant species from which its nectar was collected.
The chemical characteristics of honey encompass sugars, proteins, amino acids, enzymes, organic acids, vitamins, minerals, phenolic and volatile compounds. Chromium, zinc, and copper, among other minerals found in honey, have been shown to lower blood sugar levels, regulate glucose tolerance, and enhance insulin secretion and sensitivity in pancreatic β-cells. Numerous oligosaccharides found in honey are attributed to exhibit antihyperglycemic effects either through the regulation of gut microbiota or via the general effects of oligosaccharides.
The antimicrobial action of honey is multifactorial, involving hydrogen peroxide production, phenolic compounds, high sugar concentrations, and the presence of bee defensin-1. Various components contribute to the antibacterial efficacy of honey: the sugar content; polyphenol compounds; hydrogen peroxide; 1,2-dicarbonyl compounds; and bee defensin-1. All of these elements are present at different concentrations depending on the source of nectar, bee type, and storage. These components work synergistically, allowing honey to be potent against a variety of microorganisms including multidrug-resistant bacteria and modulate their resistance to antimicrobial agents.
The high osmolarity of honey (driven by its concentrated sugar content) draws water out of bacterial cells by osmosis, inhibiting microbial growth. Its low pH, typically between 3.2 and 4.5, further suppresses microbial proliferation. The mechanism behind honey's bacteriostatic action has been attributed to hydroxyl radicals generated from hydrogen peroxide, a key antimicrobial component in honey.
Honey's capacity to scavenge free radicals and transform them into less harmful, more stable molecules is what gives it its antioxidant properties. By releasing hydrogen from their hydroxyl groups, phenolic compounds neutralize free radicals; the activity of the chemical is determined by the amount of groups. Antioxidant capacity of honey is important in many disease conditions and is due to a wide range of compounds including phenolics, peptides, organic acids, enzymes, and Maillard reaction products.
Honey can stimulate the production of modulator cytokines TNF-α, IL-1, and IL-6, play a significant anti-inflammatory role, help reduce the inflammatory response around the wound, and have the ability to modulate the activity of immunocompetent cells to promote wound healing. Pro-inflammatory effects of honey, such as induction of iNOS, IL-1β, and COX-2, are mediated by TLR4 signaling. In contrast, honey's anti-inflammatory actions and flavonoids induce anti-inflammatory and antioxidant pathways by inducing NRF2 target genes, including HO-1 and PRDX1.
Studies revealed that the healing effect of honey could be classified by its antibacterial, antiviral, anti-inflammatory and antioxidant properties of its components. Many clinical trials have shown honey has the ability of debridement, and this effect may be related to the increased activity of fibrinolytic protease. Overall, the various bioactive ingredients of honey work together to show a significant combined effect in preventing infection, reducing inflammation, and thus promoting wound healing.
Wound care is the area with the most substantial body of clinical evidence for honey. Sufficient evidence exists recommending the use of honey in the management of acute wounds and for mild to moderate superficial and partial thickness burns. Evidence supporting the use of honey in other areas of clinical practice is needed.
Seven randomised trials involved superficial burns, partial thickness burns, moderate to severe burns that included full thickness injury, and infected post-operative wounds. A systematic review reported that the number needed to treat with honey for good wound healing compared with antiseptic was 2.9 (95% confidence interval 1.7 to 9.7).
Honey has almost equal or slightly superior effects when compared with conventional treatments for acute wounds and superficial partial thickness burns. More randomised controlled trials with significant statistical power comparing different kinds of honey are required in order to create a strong evidence base.
For chronic wounds, a 2024 updated systematic review and meta-analysis found that the topical application of honey is an effective therapeutic approach for managing chronic wounds, but the quality of the evidence was very low due to the quality of risk of bias, inconsistency, and publication bias, highlighting the necessity for larger-scale studies with adequately powered RCTs to ensure the safety and efficacy of honey dressings in chronic wound healing.
The Cochrane systematic review on burns noted that burns healed more slowly when treated with honey followed by delayed grafting than with early excision and grafting (WMD 13.6 days, 95% CI 9.82 to 17.38 days). The quality of this evidence was downgraded for imprecision on the basis that there is only one trial with a total of 50 participants, and whilst the difference in time to healing was statistically significant and clinically important, this is a small single study.
In all three wound categories, honey seems to be a dressing with wound-healing stimulating properties. In burns there is also evidence for its antibacterial capacity. In general, honey has also been mentioned to have deodorizing, debridement, anti-inflammatory, and wound pain-reducing properties, although the evidence for these properties is rather limited.
A key limitation across this field is that honey is a natural product, and that those characteristics associated with wound healing may be affected by species of bee, geographical location and botanical origin, as well as processing and storage conditions.
Honey, a natural product with a rich history of medicinal use, has gained increasing recognition for its potent antimicrobial properties, particularly against antibiotic-resistant pathogens. Research has focused on the antimicrobial mechanisms of honey, including its efficacy against resistant bacteria, such as methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa. Certain types, such as Manuka honey, are particularly effective in clinical applications due to their higher levels of bioactive compounds. Honey has also been shown to disrupt bacterial biofilms, a major factor in antibiotic resistance, enhancing its therapeutic potential in treating chronic wounds and infections.
Recent studies have highlighted the broader therapeutic applications of honey, especially its efficacy against antibiotic-resistant bacteria such as methicillin-resistant S. aureus and Vancomycin-resistant Enterococcus. However, much of this evidence derives from in vitro studies; the translation of these findings to clinical settings requires further well-designed RCTs.
This is one of the most clinically studied oral applications of honey. The World Health Organization identifies honey as a potential demulcent treatment for cough.
The 2018 Cochrane review update included six randomised controlled trials involving 899 children, comparing honey with dextromethorphan, diphenhydramine, salbutamol, bromelin, no treatment, and placebo. Moderate-quality evidence showed that honey may be better than "no treatment" in reducing the frequency of cough (mean difference −1.05 [95% CI −1.48 to −0.62]; I²=23%; two studies, 154 participants).
A 2023 systematic review found that honey seemed to decrease cough frequency more than placebo/no treatment (range of observed effect 0.0–1.1 points) and cough medication (0.2–0.9 points). The conclusion was low quality evidence that honey may be more effective than cough medication or placebo/no treatment in relieving symptoms and improving sleep in children with acute cough. Better quality randomised, placebo-controlled blinded trials are needed to confirm the effectiveness of honey in treating acute cough in children.
This review presents low quality evidence that honey may be more effective than cough medication or placebo/no treatment in relieving symptoms and improving sleep in a child with acute cough. However, only two studies had low risk of bias, and one showed benefit while the other did not. Overall, the evidence is promising but methodologically limited by blinding difficulties (honey's distinctive taste and appearance make true placebo comparisons challenging) and heterogeneity in the types of honey studied.
The NCCIH (US National Center for Complementary and Integrative Health) recognizes that honey should not be used in children younger than 1 year of age because of the risk of botulism. A 2007 study of 105 children aged 2 to 18 years with upper respiratory infections compared honey to similar pharmacologic agents and found that parents rated honey most favorably for symptomatic relief of their child's nighttime cough and sleep difficulty due to upper respiratory tract infection.
Ancient Egyptians, Assyrians, Chinese, Greeks, and Romans employed honey for wounds and diseases of the intestine. Modern investigation of these traditional uses has produced mixed results. In vitro studies propose that honey exerts bactericidal activity against Helicobacter pylori, which causes gastritis and peptic ulcers, although a clinical trial of manuka honey therapy to induce Helicobacter eradication failed to indicate a beneficial treatment.
Natural honey exhibits bactericidal activity against many organisms including Salmonella, Shigella, Escherichia coli, Helicobacter pylori, and others in vitro, though in vitro activity does not necessarily translate to clinical efficacy. Honey may be effective as a part of oral rehydration therapy, and as a clinical trial, honey shows therapeutic effects in the treatment of infants and children admitted into hospital with gastroenteritis, indicating remarkably reduced duration of diarrhea in honey-treated patients. This evidence remains limited and requires larger RCTs to confirm.
In vitro and in vivo studies have confirmed that honey possesses a range of antioxidant, antimicrobial, antiviral, anticancer, and antidiabetic properties, and it has been shown to demonstrate protective activities on the nervous, cardiovascular, gastrointestinal, and respiratory systems. Most of the biological activities of honey are attributed to its constituent phenolic and flavonoid compounds. It has been found that the effect of honey on the cardiovascular system depends on the bioavailability of various phytochemical compounds, and on their methods of absorption and metabolization.
Clinical trials have recorded health profiles including reduction in the plasma levels of risk factors: total cholesterol, low density lipoprotein (LDL)-cholesterol, triglycerides, glucose in normal and diabetic patients, and C-reactive protein, while the health indices elevated in the blood were high density lipoprotein (HDL) cholesterol. However, many such trials are small, short-term, and not independently replicated at scale. The evidence in this area should be considered preliminary.
Many studies reported the beneficial effects of honey in reversing metabolic syndrome through its antiobesity, hypoglycaemic, hypolipidaemic, and hypotensive actions. The therapeutic effects of honey largely depend on the antioxidant and anti-inflammatory properties of its polyphenol and flavonoid contents. Polyphenols, such as caffeic acid, p-coumaric acid, and gallic acid, are some of the phenolic acids known to have antiobesity and antihyperlipidaemic properties. They could inhibit the gene expression of sterol regulatory element-binding transcription factor 1 and its target lipogenic enzyme, fatty acid synthase.
Despite its sugar content, honey has been investigated for potential antidiabetic properties. Numerous oligosaccharides found in honey are attributed to exhibit antihyperglycemic effects either through the regulation of gut microbiota or via the general effects of oligosaccharides. Chromium, zinc, and copper, among other minerals found in honey, have been shown to lower blood sugar levels, regulate glucose tolerance, and enhance insulin secretion and sensitivity in pancreatic β-cells. Polyphenols present in manuka honey have been known to play a role in controlling hyperglycemia via inhibition of α-amylase and α-glucosidase, which are involved in carbohydrate breakdown. Much of this mechanistic evidence derives from animal and in vitro studies; human clinical data in this area are limited and inconclusive.
According to modern scientific literature, honey may be useful and has protective effects for the treatment of various disease conditions such as diabetes mellitus, respiratory, gastrointestinal, cardiovascular, and nervous system diseases, and it is even considered useful in cancer treatment because many types of antioxidants are present in honey. However, for most of these areas — including neurological and oncological applications — evidence remains at the in vitro or animal study level, with few or no well-designed human clinical trials to date. Honey contains many biologically active substances that regulate digestive processes and heart function, as well as showing, among others, antimicrobial, anti-inflammatory, antidiabetic, antioxidant, and anti-tumoral effects, though clinical evidence supporting these claims varies substantially in quality and quantity.
No universally standardized therapeutic dose exists for honey. Dosages reported in clinical studies vary by indication:
For medical-grade wound dressings, the most commonly studied products have been Manuka honey-based preparations (e.g., Medihoney). Medical-grade Manuka honey used in at least one study was UMF 30+; MGO 400 (procured from Comvitaâ„¢ Ltd., New Zealand).
Honey can contain the bacteria that cause botulism. Honey should not be fed to a child who is younger than 1 year old. Honey may harbor Clostridium botulinum spores, posing risks of infant botulism. Infants under one year are vulnerable due to immature gut flora, with infant botulism potentially causing severe symptoms, such as respiratory failure. This is corroborated by the U.S. Centers for Disease Control and Prevention (CDC): several babies in Texas became ill with infant botulism after using honey pacifiers. Honey is the one identified and avoidable food reservoir of C. botulinum, the bacterial spore that causes infant botulism. While most cases of infant botulism today are not caused by exposure to honey prior to illness, it is the only avoidable source of exposure to the bacteria.
Honey is a significant source of simple sugars and raises blood glucose. Honey typically has a higher concentration of fructose over glucose. Fructose is much lower on the GI scale than glucose, resulting in less of a blood sugar spike. Nevertheless, individuals with diabetes or insulin resistance should account for honey's carbohydrate contribution to overall dietary intake.
Individuals allergic to bee venom, bee products, or specific pollens may experience allergic reactions to honey, given that it naturally contains pollen and bee-derived proteins. Reactions can range from mild (oral allergy syndrome) to severe (anaphylaxis), though severe reactions are uncommon in the general population.
The composition of honey varies based on its floral source, which can influence its antimicrobial strength. Honey can be adulterated with high-fructose corn syrup or other sugars. Studies have estimated that significantly more "manuka honey" is sold worldwide than is actually produced in New Zealand. This underscores the importance of selecting honey from reputable, certified sources for any therapeutic application.
Certain plant species, particularly members of the family Ericaceae (e.g., rhododendron), produce nectar containing grayanotoxins. Honey derived from these plants — sometimes called "mad honey" — can cause poisoning characterized by bradycardia, hypotension, dizziness, and nausea. This is a well-documented phenomenon, particularly associated with honey from the Black Sea region of Turkey, but it is relevant to any region where these plants are foraged by bees.
In vitro studies showed that none of the tested honey samples had a synergistic effect with either clarithromycin or amoxicillin against H. pylori, suggesting no pharmacokinetic enhancement of these antibiotics by honey. No well-documented clinically significant drug–drug interactions with honey have been established in the peer-reviewed literature to date; however, honey's polyphenol content may, in theory, interact with drug-metabolizing enzyme systems (e.g., CYP450) similarly to other polyphenol-rich foods, though this has not been systematically evaluated in humans.
Honey is a fermentable carbohydrate and, like other sugars, is cariogenic (capable of promoting dental caries) when in prolonged contact with tooth enamel. Its caloric density (approximately 60 kcal per tablespoon) is comparable to other sugars and is relevant in the context of caloric balance.
The chemical characteristics of compounds present in honey, their stability when heated or stored for long periods of time, and the parameters of identity and quality are important considerations. The stability of these compounds in relation to the chemical reactions that occur by heating or prolonged storage, with increased understanding of the behavior regarding the common processing of honey, may compromise its quality. Heat treatment and prolonged storage accelerate Maillard reactions and increase 5-hydroxymethylfurfural (HMF) content, a marker of overprocessing.
Health conditions that Honey may help support.
Honey has documented clinical evidence as a topical treatment for infected wounds and abscesses. A published RCT found honey comparable to standard antiseptic dressings for healing incised abscess wounds. Medically certified honey preparations (e.g., Manuka/Medihoney) are licensed wound-care products in Europe and Australia.
Topical honey, particularly kanuka and manuka varieties, has antimicrobial activity against Cutibacterium acnes and has been tested in clinical trials for facial acne. A 2016 RCT (BMJ Open, n=136) tested 90% medical-grade kanuka honey on acne but did not show added clinical benefit over antibacterial soap alone. In vitro evidence supports antibacterial action, but robust human clinical proof of efficacy remains limited.
A clinical pilot study (PMC 2018) found that a topical mixture of honey, olive oil, and beeswax significantly reduced pain, bleeding, and itching in anal fissure patients with no adverse effects. Honey's antimicrobial, anti-inflammatory, and wound-healing properties (osmotic effect, hydrogen peroxide generation, high viscosity) make it mechanistically suitable for anorectal wound healing. It is also cited in traditional medicine for anorectal conditions.
Honey is a rich source of phenolic compounds, flavonoids, and enzymes including glucose oxidase that confer antioxidant activity. Human studies consistently demonstrate increased plasma antioxidant capacity after honey consumption, and darker honey varieties (buckwheat) show the highest polyphenol content and ORAC values. Clinical reviews confirm these antioxidant properties translate to reduced markers of oxidative stress.
Honey functions as an effective carbohydrate source for athletes, with small RCTs demonstrating improved endurance performance compared to placebo. A systematic review (2018, ScienceDirect) identified three RCTs confirming that acute honey ingestion improved endurance performance in two of them. Its mixed fructose/glucose composition supports sustained carbohydrate oxidation during prolonged exercise.
Honey's high osmotic pressure and antimicrobial properties can reduce oral bacteria responsible for volatile sulfur compound production, thereby improving halitosis. A 2021 clinical study in stroke patients found honey reduced halitosis scores, with honey outperforming chlorhexidine mouthwash. Ancient Egyptian texts from 1550 BCE also document honey in formulations for bad breath.
Honey has documented antibacterial, anti-inflammatory, and wound-healing properties applied to insect bites and stings to prevent infection, reduce swelling, and relieve itching. It is consistently cited in integrative medicine resources as a topical natural treatment for bites. Multiple EBSCO and clinical sources confirm honey relieves itching and inflammation when applied topically to bites.
Honey has demonstrated clinical efficacy for HSV-induced fever blisters superior to acyclovir in a 2021 systematic review and meta-analysis, inducing complete re-epithelialization of herpetic blisters in 8 days versus 9 days for acyclovir. It has thousands of years of traditional use for wound healing and blister management globally.
Multiple clinical trials and systematic reviews have assessed honey's effects on blood glucose. Evidence is mixed: honey may modestly reduce fasting blood glucose and HbA1c in some populations when substituted for refined sugar, but high doses can worsen glycemic control in type 2 diabetes. A 2022 meta-analysis and 2025 umbrella review both note that 10 g/day substituted for simple sugars may positively influence HbA1c.
Honey has documented efficacy for reducing cough and improving respiratory symptoms in upper respiratory tract infections, supported by a 2018 Cochrane systematic review of six RCTs (899 children). Honey probably reduces cough symptoms more than placebo and was more effective than salbutamol at relieving cough for up to three days. Traditional use of honey for bronchial complaints spans millennia across multiple cultures.
Honey is supported by a clinical randomized trial for managing acute bronchitis. A 2023 multiarm RCT (Llor et al., Family Practice) compared honey versus antitussives and anticholinergics for uncomplicated acute bronchitis, finding honey to be an effective usual-care alternative. WHO endorses honey as a demulcent for cough and respiratory tract irritation.
Multiple systematic reviews and meta-analyses demonstrate honey's superiority over conventional dressings (including silver sulfadiazine) for healing superficial and partial-thickness burns. A Cochrane-reviewed meta-analysis found odds ratios of 6.1–6.7 in favor of honey for healing at 15 days. Honey's antimicrobial, anti-inflammatory, antioxidant, and wound-debriding properties are well-documented.
Honey has been evaluated in RCTs for recurrent aphthous stomatitis. A randomized, blind, double-center clinical trial (Quintessence International, 2014) comparing honey to topical corticosteroid found honey effective in reducing pain, ulcer size, and erythema in a Saudi cohort with minor aphthous ulcers. A PMC-indexed biochemical evaluation study and a separate RCT (vs. steroid gel and OTC paste) further support honey's efficacy, attributed to its antimicrobial, osmotic, and anti-inflammatory properties.
Honey has been shown in multiple pediatric RCTs to reduce the frequency, severity, and duration of cough associated with upper respiratory infections, effectively supporting children's immune response to common viral illness. Cochrane evidence (2018, 6 RCTs, 899 children) confirms honey is superior to placebo and no-treatment for cough symptoms. Traditional use in pediatric febrile illness spans ancient medical systems.
Clinical trials show honey reduces total cholesterol, LDL-C, and raises HDL-C when substituted for sucrose. The Al-Waili RCT (n=55) found honey reduced total cholesterol by 3–3.3% and LDL-C by 4.3–5.8% versus sucrose. GRADE-assessed meta-analyses confirm modest but statistically significant improvements in lipid profiles with regular honey intake.
Honey modulates key inflammatory signaling pathways including NF-κB and MAPK, reducing pro-inflammatory cytokines (IL-1β, IL-6, TNF-α) and CRP. Clinical evidence includes a human trial showing honey reduced CRP by 3.2% versus sucrose, and multiple reviews confirm anti-inflammatory activity in cell culture, animal, and human models.
Honey has strong clinical evidence as a nighttime cough suppressant in children with upper respiratory infections. Multiple RCTs and a 2018 Cochrane review found honey reduces nocturnal cough frequency and severity better than placebo and several OTC cough medications in children aged 1 year and older. The AAFP and NCCIH recognize honey as one of very few safe and effective treatments for cold-associated cough in children.
Medical-grade honey (kanuka, manuka) has been evaluated in clinical RCTs for herpes labialis. A large RCT (BMJ Open 2019, n=952) found kanuka honey was as effective as topical acyclovir. A clinical study found medical-grade honey (L-Mesitran) outperformed conventional cold sore treatments in healing time and symptom relief. A 2026 meta-analysis confirmed honey alongside propolis showed superior healing to acyclovir.
A published clinical trial (Al-Waili, Eur J Med Res, 2001; n=30 patients) found that topical application of 90% crude honey every other day for 4 weeks produced significant improvement in dandruff and seborrheic dermatitis, with all patients improving and no relapse during 6-month maintenance. Honey's mechanism involves osmotic antimicrobial action against Malassezia, hydrogen peroxide generation, and antifungal polyphenols.
Honey, particularly manuka honey (from Leptospermum scoparium), has clinical and mechanistic evidence for atopic dermatitis. A clinical and cellular study found manuka honey was potentially effective for AD lesions, significantly downregulating IL-4-induced CCL26 from keratinocytes and inhibiting mast cell degranulation. Traditional use spans millennia.
Honey was evaluated alongside olive oil and beeswax in a clinical study (Al-Waili, Clin Microbiol Infect, 2005; 11:160-163) that reported clinical and mycological benefits in diaper dermatitis, including reduced erythema and Candida colonization. A 2023 clinical trial (NCT06134505) also assessed bee products including honey components for diaper dermatitis.
Thyme honey oral rinse was evaluated in a single-blind RCT of 28 geriatric ESRD patients with xerostomia, significantly improving subjective and objective dry mouth scores, salivary flow rate, and salivary pH versus saline. A 2025 BMC Oral Health RCT demonstrated Manuka honey rinse significantly improved xerostomia, salivary flow, and quality of life in elderly adults.
Honey's humectant, emollient, and antimicrobial properties support skin hydration and barrier function. Reviews of honey phytochemicals (2024, Phytotherapy Research) document its skin barrier-enhancing, anti-inflammatory, and wound-healing properties. Clinical studies of honey in atopic dermatitis (a condition marked by dry, inflamed skin) have shown benefit.
Honey, particularly manuka honey, has demonstrated broad-spectrum antimicrobial and anti-inflammatory properties relevant to atopic dermatitis. Clinical and mechanistic studies published in peer-reviewed journals support its potential as a topical treatment adjunct for AD, primarily through inhibiting S. aureus and modulating inflammatory pathways.
Honey demonstrates in vitro antibacterial activity against Helicobacter pylori, the primary cause of chronic gastritis, and has been proposed as an adjunct to standard eradication therapy. In vitro studies (PMC3074916) confirm some honey types inhibit H. pylori, and honey inhibits H. pylori urease activity. Human clinical trial evidence specifically targeting H. pylori-associated gastritis remains limited.
Honey, particularly manuka, inhibits key periodontal pathogens including Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans, and clinical studies have shown reductions in plaque scores and gingival bleeding. A systematic review on apitherapy and periodontal disease (PMC9137511) summarizes in vitro, animal, and clinical trial evidence supporting honey's role in periodontal management.
Honey contains non-digestible oligosaccharides that may act as prebiotics, selectively promoting beneficial gut bacteria including bifidobacteria and lactobacilli. A 2022 Frontiers in Nutrition review (PMC9367972) summarizes in vitro, animal, and pilot human study evidence supporting honey's prebiotic capability. Evidence from controlled human trials is growing but still preliminary.
Clinical studies demonstrate that substituting honey for sucrose reduces multiple cardiovascular risk factors including total cholesterol, LDL-C, triglycerides, CRP, and fasting blood glucose. A 2022 GRADE-assessed meta-analysis and a 2025 umbrella review confirm modest beneficial effects on cardiometabolic markers with daily honey consumption.
Honey is a clinically recognized fast-acting carbohydrate for treating mild-to-moderate hypoglycemia, recommended in hospital and cancer center protocols. Containing glucose and fructose, its glucose fraction raises blood sugar within minutes. Memorial Sloan Kettering's hypoglycemia protocol specifically lists 1 tablespoon of honey as an acceptable rapid-acting sugar for blood glucose rescue.
Honey has extensive clinical evidence for cough relief and mucus-associated respiratory symptoms. A meta-analysis including 14 RCTs found honey more effective than usual care for cough frequency and severity in upper respiratory tract infections. Mayo Clinic references the Cochrane Database review supporting honey for calming coughs, and it soothes irritated mucous membranes via mechanical coating and antimicrobial effects.
Honey, particularly manuka, inhibits key oral pathogens including Streptococcus mutans, Porphyromonas gingivalis, and Aggregatibacter actinomycetemcomitans, and has been shown to reduce plaque indices in clinical studies. Its bactericidal activity against oral pathogens is well characterized in vitro, and clinical trials in periodontal patients demonstrate microbiome-modulating effects.
Honey has broad-spectrum antimicrobial, antiviral, and anti-inflammatory properties with evidence in viral pneumonia contexts. A clinical study in COVID-19 patients showed honey plus Nigella sativa produced earlier viral clearance and reduced mortality versus standard care. NICE and PHE recommend honey as first-line treatment for acute cough from upper respiratory infection.
Topical honey, particularly in combination with beeswax and olive oil, has been tested in a partially controlled clinical trial for psoriasis, showing improvement in scaling and erythema. A 2024 Phytotherapy Research review confirmed honey phytochemicals have anti-inflammatory, antioxidant, and antiproliferative properties relevant to psoriasis management.
Honey reduces cough frequency and severity in upper respiratory tract infections, which are the dominant seasonal respiratory ailment. A 2021 BMJ Evidence-Based Medicine systematic review and meta-analysis confirmed honey's effectiveness for symptomatic relief in URTIs. Its antibacterial and anti-inflammatory properties may also reduce secondary bacterial superinfection during seasonal illness.
Honey, particularly Manuka honey, has demonstrated antibiofilm activity against chronic rhinosinusitis pathogens in vitro superior to common antibiotics in some studies. A clinical trial (Di Stadio et al., Healthcare 2022) included honey in a nutraceutical protocol for upper RTI/sinusitis. Traditional use across cultures for respiratory infections is established.
Honey has shown improvement in nocturnal sleep quality in children with cough due to upper respiratory infections across multiple RCTs. The 2018 Cochrane review confirmed honey is more effective than no treatment and placebo for improving children's sleep impacted by cough. Limited adult sleep evidence exists beyond this pediatric cough context.
Honey has robust clinical and systematic-review evidence for sore throat and cough relief. It acts as a demulcent, coating irritated throat tissue, and exerts antimicrobial and anti-inflammatory effects via hydrogen peroxide, lysozyme, and phenolic compounds. A 2020 BMJ-published meta-analysis and Cochrane review support its efficacy. The WHO also recommends it for upper respiratory tract symptom relief.
Clinical trials show that honey consumption reduces serum triglycerides, particularly in individuals with elevated baseline values. The Al-Waili RCT (n=55) found 70 g/day honey for 30 days reduced triglycerides by 11% in normal individuals and 19% in those with elevated levels versus sucrose. GRADE-assessed meta-analyses confirm honey's modest triglyceride-lowering effect.
Honey, particularly manuka honey, has demonstrated anti-H. pylori, antioxidant, and anti-inflammatory effects in animal models of gastric ulcer. A rat study (acetic acid-induced chronic gastric ulcer) found manuka honey significantly reduced ulcer index, inflammatory cytokines (TNF-α, IL-1β, IL-6), and oxidative stress markers. Clinical use for wound/skin ulcers is supported by RCT evidence.
Honey has clinical RCT evidence for nocturnal cough in children with upper respiratory infections. A landmark 2007 RCT (n=105 children) found buckwheat honey significantly outperformed dextromethorphan and no treatment for URTI-related cough. WHO and multiple guidelines recognize honey as a low-cost option for childhood cough associated with URTI.
Manuka honey has demonstrated inhibitory effects against influenza and varicella-zoster viruses, and oral honey has potentiated antiviral drug responses in preclinical and early clinical evidence. A 2020/21 review (Heliyon/PMC) documents honey's immune-modulating properties including stimulation of MAIT cells by methylglyoxal (MGO) and suppression of NF-κB and MAPK inflammatory signaling relevant to viral immunity.
Honey, particularly Manuka honey, has substantial evidence for wound healing including antimicrobial activity against MRSA, stimulation of angiogenesis, moist wound environment maintenance, and anti-inflammatory effects. Multiple systematic reviews and RCTs confirm its efficacy in burn wounds, chronic ulcers, and surgical wounds.
Honey has a long history of traditional use for diarrhea in Ayurvedic, Islamic, and Greek medicine, attributed to its antibacterial properties against intestinal pathogens. While in vitro evidence demonstrates antimicrobial activity against bacteria relevant to infectious diarrhea, robust human clinical trial evidence specifically for honey as a diarrhea treatment is lacking.
Honey has been used for millennia across virtually all traditional medical systems (Ayurvedic, Greek, Egyptian, Chinese, Islamic) as a longevity food and medicine. It contains polyphenols, hydrogen peroxide, methylglyoxal (Manuka), and unique carbohydrate structures with antioxidant and antimicrobial properties relevant to aging. Modern evidence is primarily dietary/epidemiological.
Honey has been used in traditional medicine across Greek, Ayurvedic, Egyptian, and Islamic medicine for millennia as a wound-healing and convalescent restorative. Methylglyoxal (in Manuka honey) and hydrogen peroxide have documented antimicrobial properties. Clinical evidence supports honey for cough reduction and wound healing during post-illness recovery.
Body systems that Honey may help support.
Go back